DIANE PINKARD: Open Payments
NPI 1659373710 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,914 in 71 payments from 16 companies in 2025. Trend: 2023 $2,167 · 2024 $1,633 · 2025 $2,914
Food & beverage: $2,824Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $1,138 |
| Regeneron Healthcare Solutions, Inc. | 12 | $400 |
| CSL Behring | 7 | $281 |
| GlaxoSmithKline, LLC. | 12 | $222 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $144 |
| GENZYME CORPORATION | 2 | $128 |
| Novo Nordisk Inc | 1 | $110 |
| Lilly USA, LLC | 1 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Genentech, Inc. | 1 | $80 |
Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, NEFFY, NUCALA, XOLAIR, Ozempic, Andembry.
Industry payments across TN — which companies pay providers there.
